| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 5.84e-08 | 5 | 37 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 3.33e-05 | 5 | 37 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 6.97e-05 | 7 | 37 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | glucosidase activity | 3.46e-04 | 15 | 37 | 2 | GO:0015926 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 9.12e-04 | 103 | 37 | 3 | GO:0004553 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 2.38e-03 | 144 | 37 | 3 | GO:0016798 | |
| GeneOntologyBiologicalProcess | disaccharide catabolic process | 1.87e-05 | 4 | 37 | 2 | GO:0046352 | |
| GeneOntologyBiologicalProcess | neuromuscular synaptic transmission | 3.64e-05 | 36 | 37 | 3 | GO:0007274 | |
| GeneOntologyCellularComponent | manchette | 1.62e-05 | 28 | 37 | 3 | GO:0002177 | |
| GeneOntologyCellularComponent | interstitial matrix | 4.08e-04 | 17 | 37 | 2 | GO:0005614 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 6.32e-04 | 223 | 37 | 4 | GO:0098862 | |
| MousePheno | ectopic manchette | 8.44e-06 | 19 | 30 | 3 | MP:0009377 | |
| MousePheno | detached sperm flagellum | 1.16e-05 | 21 | 30 | 3 | MP:0008893 | |
| MousePheno | detached acrosome | 1.11e-04 | 44 | 30 | 3 | MP:0009231 | |
| MousePheno | abnormal manchette morphology | 1.19e-04 | 45 | 30 | 3 | MP:0009376 | |
| MousePheno | absent intervertebral disk | 1.24e-04 | 8 | 30 | 2 | MP:0004683 | |
| MousePheno | kinked sperm flagellum | 2.29e-04 | 56 | 30 | 3 | MP:0009237 | |
| MousePheno | abnormal notochord morphology | 3.25e-04 | 63 | 30 | 3 | MP:0002825 | |
| Domain | Glyco_hydro_31_CS | 2.16e-05 | 4 | 36 | 2 | IPR030459 | |
| Domain | NtCtMGAM_N | 2.16e-05 | 4 | 36 | 2 | PF16863 | |
| Domain | Gal_mutarotase_N | 2.16e-05 | 4 | 36 | 2 | IPR031727 | |
| Domain | GLYCOSYL_HYDROL_F31_2 | 3.60e-05 | 5 | 36 | 2 | PS00707 | |
| Domain | Glyco_hydro_31_AS | 5.39e-05 | 6 | 36 | 2 | IPR030458 | |
| Domain | Glyco_hydro_31 | 7.54e-05 | 7 | 36 | 2 | PF01055 | |
| Domain | Glyco_hydro_31 | 7.54e-05 | 7 | 36 | 2 | IPR000322 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 7.54e-05 | 7 | 36 | 2 | PS00129 | |
| Domain | Trefoil | 1.00e-04 | 8 | 36 | 2 | PF00088 | |
| Domain | P_TREFOIL_1 | 1.00e-04 | 8 | 36 | 2 | PS00025 | |
| Domain | P_trefoil_CS | 1.00e-04 | 8 | 36 | 2 | IPR017957 | |
| Domain | P_TREFOIL_2 | 1.29e-04 | 9 | 36 | 2 | PS51448 | |
| Domain | PD | 1.29e-04 | 9 | 36 | 2 | SM00018 | |
| Domain | - | 1.97e-04 | 11 | 36 | 2 | 4.10.110.10 | |
| Domain | P_trefoil_dom | 2.36e-04 | 12 | 36 | 2 | IPR000519 | |
| Domain | SH3_9 | 4.53e-04 | 78 | 36 | 3 | PF14604 | |
| Domain | Gal_mutarotase_SF_dom | 4.82e-04 | 17 | 36 | 2 | IPR011013 | |
| Domain | SH3_2 | 6.03e-04 | 86 | 36 | 3 | IPR011511 | |
| Domain | SH3_2 | 6.03e-04 | 86 | 36 | 3 | PF07653 | |
| Domain | - | 1.53e-03 | 663 | 36 | 6 | 2.60.40.10 | |
| Domain | Abhydrolase_1 | 1.62e-03 | 31 | 36 | 2 | PF00561 | |
| Domain | AB_hydrolase_1 | 1.84e-03 | 33 | 36 | 2 | IPR000073 | |
| Domain | Ig-like_fold | 2.11e-03 | 706 | 36 | 6 | IPR013783 | |
| Domain | Glycoside_hydrolase_SF | 4.68e-03 | 53 | 36 | 2 | IPR017853 | |
| Domain | FN3 | 6.57e-03 | 199 | 36 | 3 | PS50853 | |
| Domain | FN3_dom | 7.52e-03 | 209 | 36 | 3 | IPR003961 | |
| Domain | SH3 | 8.22e-03 | 216 | 36 | 3 | PS50002 | |
| Domain | SH3 | 8.22e-03 | 216 | 36 | 3 | SM00326 | |
| Domain | SH3_domain | 8.65e-03 | 220 | 36 | 3 | IPR001452 | |
| Pathway | PID_HEDGEHOG_GLI_PATHWAY | 6.25e-05 | 48 | 23 | 3 | M219 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 7.09e-05 | 8 | 23 | 2 | MM14717 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.39e-04 | 11 | 23 | 2 | M1091 | |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 4.81e-09 | 4 | 38 | 3 | 19091768 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 1.20e-08 | 5 | 38 | 3 | 17855024 | |
| Pubmed | Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library. | 4.34e-07 | 14 | 38 | 3 | 17662146 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 27480812 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 36968271 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 20356844 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 11352564 | ||
| Pubmed | Transcriptional activation of Hedgehog pathway components in aggressive haemangioma. | 3.48e-06 | 3 | 38 | 2 | 28370639 | |
| Pubmed | Activation of Hedgehog Signaling in Aggressive Hepatic Hemangioma in Newborns and Infants. | 3.48e-06 | 3 | 38 | 2 | 31092427 | |
| Pubmed | Partial characterization of murine intestinal maltase-glucoamylase. | 3.48e-06 | 3 | 38 | 2 | 12150962 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 31558698 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 23988578 | ||
| Pubmed | Regulation of adipogenesis by nuclear receptor PPARγ is modulated by the histone demethylase JMJD2C. | 6.96e-06 | 4 | 38 | 2 | 21637537 | |
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 9118802 | ||
| Pubmed | Gli1 is a target of Sonic hedgehog that induces ventral neural tube development. | 1.16e-05 | 5 | 38 | 2 | 9216996 | |
| Pubmed | Essential function of Gli2 and Gli3 in the formation of lung, trachea and oesophagus. | 2.43e-05 | 7 | 38 | 2 | 9731531 | |
| Pubmed | 2.43e-05 | 7 | 38 | 2 | 22441348 | ||
| Pubmed | Ski is involved in transcriptional regulation by the repressor and full-length forms of Gli3. | 2.43e-05 | 7 | 38 | 2 | 12435627 | |
| Pubmed | 3.24e-05 | 8 | 38 | 2 | 30301781 | ||
| Pubmed | 4.16e-05 | 9 | 38 | 2 | 20081843 | ||
| Pubmed | Context-dependent ciliary regulation of hedgehog pathway repression in tissue morphogenesis. | 4.16e-05 | 9 | 38 | 2 | 37943875 | |
| Pubmed | Hedgehog signaling regulates FOXA2 in esophageal embryogenesis and Barrett's metaplasia. | 4.16e-05 | 9 | 38 | 2 | 25083987 | |
| Pubmed | 4.16e-05 | 9 | 38 | 2 | 32179481 | ||
| Pubmed | Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation. | 4.16e-05 | 9 | 38 | 2 | 10725236 | |
| Pubmed | Gli2, but not Gli1, is required for initial Shh signaling and ectopic activation of the Shh pathway. | 4.16e-05 | 9 | 38 | 2 | 12361967 | |
| Pubmed | The loss of Hh responsiveness by a non-ciliary Gli2 variant. | 4.16e-05 | 9 | 38 | 2 | 25834022 | |
| Pubmed | 4.16e-05 | 9 | 38 | 2 | 20516201 | ||
| Pubmed | 4.18e-05 | 177 | 38 | 4 | 26206133 | ||
| Pubmed | 5.20e-05 | 10 | 38 | 2 | 28939119 | ||
| Pubmed | 5.20e-05 | 10 | 38 | 2 | 23166838 | ||
| Pubmed | Differential requirement for Gli2 and Gli3 in ventral neural cell fate specification. | 5.20e-05 | 10 | 38 | 2 | 12812795 | |
| Pubmed | 5.20e-05 | 10 | 38 | 2 | 9247260 | ||
| Pubmed | 5.20e-05 | 10 | 38 | 2 | 27849569 | ||
| Pubmed | 5.20e-05 | 10 | 38 | 2 | 11748151 | ||
| Pubmed | 6.35e-05 | 11 | 38 | 2 | 28673820 | ||
| Pubmed | Distinct Activities of Gli1 and Gli2 in the Absence of Ift88 and the Primary Cilia. | 6.35e-05 | 11 | 38 | 2 | 30791390 | |
| Pubmed | Mouse Rab23 regulates hedgehog signaling from smoothened to Gli proteins. | 6.35e-05 | 11 | 38 | 2 | 16364285 | |
| Pubmed | Sonic hedgehog signaling directs patterned cell remodeling during cranial neural tube closure. | 6.35e-05 | 11 | 38 | 2 | 33103996 | |
| Pubmed | 7.62e-05 | 12 | 38 | 2 | 28264835 | ||
| Pubmed | Dual function of suppressor of fused in Hh pathway activation and mouse spinal cord patterning. | 7.62e-05 | 12 | 38 | 2 | 22182519 | |
| Pubmed | IFT25 links the signal-dependent movement of Hedgehog components to intraflagellar transport. | 7.62e-05 | 12 | 38 | 2 | 22595669 | |
| Pubmed | Spop regulates Gli3 activity and Shh signaling in dorsoventral patterning of the mouse spinal cord. | 7.62e-05 | 12 | 38 | 2 | 28412462 | |
| Pubmed | The novel ciliogenesis regulator DYRK2 governs Hedgehog signaling during mouse embryogenesis. | 7.62e-05 | 12 | 38 | 2 | 32758357 | |
| Pubmed | 7.62e-05 | 12 | 38 | 2 | 21337666 | ||
| Pubmed | 9.00e-05 | 13 | 38 | 2 | 21093585 | ||
| Pubmed | T396I mutation of mouse Sufu reduces the stability and activity of Gli3 repressor. | 9.00e-05 | 13 | 38 | 2 | 25760946 | |
| Pubmed | Diminished Sonic hedgehog signaling and lack of floor plate differentiation in Gli2 mutant mice. | 9.00e-05 | 13 | 38 | 2 | 9636069 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 9.07e-05 | 420 | 38 | 5 | 28065597 | |
| Pubmed | 1.05e-04 | 14 | 38 | 2 | 20463034 | ||
| Pubmed | 1.05e-04 | 14 | 38 | 2 | 22549777 | ||
| Pubmed | Mouse Kif7/Costal2 is a cilia-associated protein that regulates Sonic hedgehog signaling. | 1.05e-04 | 14 | 38 | 2 | 19666503 | |
| Pubmed | Complex interactions between genes controlling trafficking in primary cilia. | 1.05e-04 | 14 | 38 | 2 | 21552265 | |
| Pubmed | 1.05e-04 | 14 | 38 | 2 | 21664576 | ||
| Pubmed | 1.21e-04 | 15 | 38 | 2 | 25458012 | ||
| Pubmed | 1.21e-04 | 15 | 38 | 2 | 30237242 | ||
| Pubmed | 1.38e-04 | 16 | 38 | 2 | 28800946 | ||
| Pubmed | 1.38e-04 | 16 | 38 | 2 | 9655799 | ||
| Pubmed | 1.38e-04 | 16 | 38 | 2 | 31964774 | ||
| Pubmed | Identification and characterization of VPO1, a new animal heme-containing peroxidase. | 1.38e-04 | 16 | 38 | 2 | 18929642 | |
| Pubmed | Ciliary and extraciliary Gpr161 pools repress hedgehog signaling in a tissue-specific manner. | 1.38e-04 | 16 | 38 | 2 | 34346313 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | 1.40e-04 | 1070 | 38 | 7 | 23533145 | |
| Pubmed | 1.76e-04 | 18 | 38 | 2 | 14645126 | ||
| Pubmed | 1.96e-04 | 19 | 38 | 2 | 23332756 | ||
| Pubmed | 1.96e-04 | 19 | 38 | 2 | 22698544 | ||
| Pubmed | Quantitative lineage analysis identifies a hepato-pancreato-biliary progenitor niche. | 1.96e-04 | 19 | 38 | 2 | 34433966 | |
| Pubmed | Cell Cycle-Related Kinase (CCRK) regulates ciliogenesis and Hedgehog signaling in mice. | 1.96e-04 | 19 | 38 | 2 | 28817564 | |
| Pubmed | 1.96e-04 | 19 | 38 | 2 | 19686689 | ||
| Pubmed | 2.18e-04 | 20 | 38 | 2 | 28379358 | ||
| Pubmed | 2.18e-04 | 20 | 38 | 2 | 21045211 | ||
| Pubmed | 2.18e-04 | 20 | 38 | 2 | 32702291 | ||
| Pubmed | Temporal and spatial requirements of Smoothened in ventral midbrain neuronal development. | 2.41e-04 | 21 | 38 | 2 | 23618354 | |
| Pubmed | 2.41e-04 | 21 | 38 | 2 | 32855417 | ||
| Pubmed | 2.41e-04 | 21 | 38 | 2 | 29659575 | ||
| Pubmed | 2.41e-04 | 21 | 38 | 2 | 22007132 | ||
| Pubmed | Differential requirement of SUFU in tissue development discovered in a hypomorphic mouse model. | 2.41e-04 | 21 | 38 | 2 | 28688895 | |
| Pubmed | 2.65e-04 | 22 | 38 | 2 | 19223390 | ||
| Pubmed | Broad-minded links cell cycle-related kinase to cilia assembly and hedgehog signal transduction. | 2.65e-04 | 22 | 38 | 2 | 20159594 | |
| Pubmed | Cbln1 regulates axon growth and guidance in multiple neural regions. | 2.65e-04 | 22 | 38 | 2 | 36395107 | |
| Pubmed | 2.65e-04 | 22 | 38 | 2 | 21775418 | ||
| Pubmed | 2.90e-04 | 23 | 38 | 2 | 16459298 | ||
| Pubmed | 2.90e-04 | 23 | 38 | 2 | 30814516 | ||
| Pubmed | 2.90e-04 | 23 | 38 | 2 | 21937600 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 3.18e-04 | 861 | 38 | 6 | 36931259 | |
| Pubmed | Wnt signaling determines ventral spinal cord cell fates in a time-dependent manner. | 3.43e-04 | 25 | 38 | 2 | 18927156 | |
| Pubmed | 3.43e-04 | 25 | 38 | 2 | 29487109 | ||
| Pubmed | 3.72e-04 | 26 | 38 | 2 | 28087629 | ||
| Pubmed | Deficiency of Wdr60 and Wdr34 cause distinct neural tube malformation phenotypes in early embryos. | 3.72e-04 | 26 | 38 | 2 | 37228654 | |
| Pubmed | 4.01e-04 | 27 | 38 | 2 | 19168680 | ||
| Pubmed | 4.01e-04 | 27 | 38 | 2 | 25631042 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 4.13e-04 | 583 | 38 | 5 | 29844126 | |
| Pubmed | 4.32e-04 | 28 | 38 | 2 | 26884322 | ||
| Pubmed | The small GTPase RSG1 controls a final step in primary cilia initiation. | 4.32e-04 | 28 | 38 | 2 | 29038301 | |
| Pubmed | 4.63e-04 | 29 | 38 | 2 | 27320915 | ||
| Pubmed | 4.63e-04 | 29 | 38 | 2 | 21209331 | ||
| Pubmed | 4.96e-04 | 30 | 38 | 2 | 25804738 | ||
| Pubmed | 4.96e-04 | 30 | 38 | 2 | 23482494 | ||
| Pubmed | 4.96e-04 | 30 | 38 | 2 | 24302887 | ||
| Pubmed | 5.30e-04 | 31 | 38 | 2 | 22889265 | ||
| Pubmed | 5.65e-04 | 32 | 38 | 2 | 19286674 | ||
| Pubmed | ZBTB18 inhibits SREBP-dependent lipid synthesis by halting CTBPs and LSD1 activity in glioblastoma. | 6.01e-04 | 33 | 38 | 2 | 36414381 | |
| Interaction | CCDC6 interactions | 1.24e-05 | 286 | 37 | 6 | int:CCDC6 | |
| Cytoband | 22q11.21 | 1.09e-04 | 111 | 38 | 3 | 22q11.21 | |
| Cytoband | 10q22.2 | 5.36e-04 | 41 | 38 | 2 | 10q22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q11 | 5.02e-03 | 419 | 38 | 3 | chr22q11 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.48e-02 | 161 | 21 | 2 | 593 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-07 | 184 | 38 | 5 | 89ae8bf1a6c2d355d279d23a5e24a08d9ec2334e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-07 | 184 | 38 | 5 | 34c84ac9a32eaf96f45b79485119cad65905817d | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-07 | 191 | 38 | 5 | 8597a8af294f24496c317d995f07eb5dcc25c13c | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-07 | 194 | 38 | 5 | 80be44e9ddd9f6ddd9dff7cba0eb457431204c2d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-07 | 194 | 38 | 5 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 6.49e-07 | 195 | 38 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.66e-07 | 196 | 38 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.00e-07 | 198 | 38 | 5 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Ccnd1_(Mural.Rgs5Acta2.Ccnd1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.00e-06 | 89 | 38 | 4 | 42432936a6b4289cc4b42fcb576fb09073f2264b | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Ccnd1_(Mural.Rgs5Acta2.Ccnd1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.00e-06 | 89 | 38 | 4 | 6c594e13f169970b337c2fc3ab969faf6db1a27a | |
| ToppCell | C_02|World / shred on cell type and cluster | 1.17e-05 | 165 | 38 | 4 | a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d | |
| ToppCell | Club_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.28e-05 | 169 | 38 | 4 | 03b303af8a26c6ff196507fe24f5bd3d75d7b1af | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.41e-05 | 173 | 38 | 4 | 51328a60ffaf34fa0f7df6084d348b5efc9917f5 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.41e-05 | 173 | 38 | 4 | b77cd5dbda3a206922f20224f4e10a3bf712f7db | |
| ToppCell | Entopeduncular-Endothelial-MURAL|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.51e-05 | 176 | 38 | 4 | b8e52bec78876562a25f0b0de502aa9372b28bd2 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.51e-05 | 176 | 38 | 4 | 10c1f31c27e54b70f58f0b0086ac74dee2ce4197 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-05 | 177 | 38 | 4 | 30f82b04e48940bfcaf2c22677efe6d57ae3f1a7 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-05 | 177 | 38 | 4 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-05 | 178 | 38 | 4 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.57e-05 | 178 | 38 | 4 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.72e-05 | 182 | 38 | 4 | ba066ff9029cc052b76e2330ec168cb2e9b7e498 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-05 | 183 | 38 | 4 | 2beb5414958d38a5341870d55229f3b1707e76bf | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-05 | 183 | 38 | 4 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.91e-05 | 187 | 38 | 4 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 188 | 38 | 4 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.95e-05 | 188 | 38 | 4 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 189 | 38 | 4 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 189 | 38 | 4 | a959c9d6a0866582688a4204d625c1e5a123e93d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 189 | 38 | 4 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.03e-05 | 190 | 38 | 4 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 190 | 38 | 4 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.03e-05 | 190 | 38 | 4 | cf463b2f227f3cc7d3fd296c810c0cbe51cbee72 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-05 | 191 | 38 | 4 | f00d6824bd138b192a996e9f7de57b235bb24c18 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.08e-05 | 191 | 38 | 4 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | facs-MAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-05 | 191 | 38 | 4 | b4fba92f9bd1354a07fedfca7304a3757e6d5beb | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.08e-05 | 191 | 38 | 4 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.08e-05 | 191 | 38 | 4 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-05 | 192 | 38 | 4 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-05 | 192 | 38 | 4 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 192 | 38 | 4 | 3617d2bc7e33d981f3ec349e9962d8d4bd822fbd | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 2.12e-05 | 192 | 38 | 4 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-05 | 193 | 38 | 4 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 2.16e-05 | 193 | 38 | 4 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 2.16e-05 | 193 | 38 | 4 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.16e-05 | 193 | 38 | 4 | 7c0d84b92470bfda2db1e5007feee7c1235a0a78 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.21e-05 | 194 | 38 | 4 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 2.21e-05 | 194 | 38 | 4 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-05 | 194 | 38 | 4 | 7826fe5eb254ac032de0d978f39585a40e0b3ee4 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 194 | 38 | 4 | 04ecb609d233a4b12e275c604810937830363e17 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-05 | 194 | 38 | 4 | ca1f24070424b44b7a442e4fca761ebfbe24b063 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 194 | 38 | 4 | bf34737ae2dc218f890fbb9201c308b324415749 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 194 | 38 | 4 | 775600880bb77781de48085d8744c1030223de1f | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 2.21e-05 | 194 | 38 | 4 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 194 | 38 | 4 | b35e33439b6d3b5d69147e617224d2c8fd056223 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 194 | 38 | 4 | 4ebed7a6731b88c8359860072cbeba355a7e90ac | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.30e-05 | 196 | 38 | 4 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.30e-05 | 196 | 38 | 4 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 2.34e-05 | 197 | 38 | 4 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 197 | 38 | 4 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.34e-05 | 197 | 38 | 4 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.39e-05 | 198 | 38 | 4 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 2.39e-05 | 198 | 38 | 4 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.39e-05 | 198 | 38 | 4 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.39e-05 | 198 | 38 | 4 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.39e-05 | 198 | 38 | 4 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.39e-05 | 198 | 38 | 4 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-05 | 199 | 38 | 4 | 30ab0750d51f168b18c434c974d24a4e70f29cc7 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.44e-05 | 199 | 38 | 4 | 28c1722deef3b8347371c7359be7c64b95780de3 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.44e-05 | 199 | 38 | 4 | f2ad641f36c577ff7019e88ad6b73ed7e46d8c74 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-05 | 199 | 38 | 4 | 36c1deac7ef0f9ebde6b2f7a63f7daa03d8c139a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-05 | 199 | 38 | 4 | 3d8c76e3d05acf72a35ca755b51579fc3ae63562 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-05 | 199 | 38 | 4 | a272c54baf8de59c0f259e6498d144a0de8d8924 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 2.44e-05 | 199 | 38 | 4 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.44e-05 | 199 | 38 | 4 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.44e-05 | 199 | 38 | 4 | 7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.48e-05 | 200 | 38 | 4 | 747c61d4e0b746278ae1f45ca4cd556c6961c76a | |
| ToppCell | distal-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.48e-05 | 200 | 38 | 4 | 12b705dabec1b3752a488a891eda1a5123fcdc41 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Astrocyte|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 2.48e-05 | 200 | 38 | 4 | b9bd6c4381c92bfc1bfff9aa778a62a41d08f1ef | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.48e-05 | 200 | 38 | 4 | 16a7c398626b6e82b394eb3ef013bda3a788659d | |
| ToppCell | cellseq2-Mesenchymal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.48e-05 | 200 | 38 | 4 | 6b558cce0d6047c7e85f428adff80c5ca3084ea4 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.48e-05 | 200 | 38 | 4 | a637281d91e95734ee4f8510b3780e0272b16fda | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.48e-05 | 200 | 38 | 4 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-4|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.48e-05 | 200 | 38 | 4 | 7642a14855589b0b3f68dbdc9e4d3fc7291854f7 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.48e-05 | 200 | 38 | 4 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.48e-05 | 200 | 38 | 4 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.48e-05 | 200 | 38 | 4 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.48e-05 | 200 | 38 | 4 | 444c72334df421375ae6fc69b0adfd4950d49a43 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.48e-05 | 200 | 38 | 4 | 5826c17da67bdaba3a828792279004218d8260c8 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.48e-05 | 200 | 38 | 4 | de1d193f773f4e2927baa6fc38d29754b015c6e6 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Rgs5_(Mural.Rgs5Acta2.Rgs5)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.80e-05 | 69 | 38 | 3 | a157b1582401cebd222343d94086dbea876140c2 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Rgs5_(Mural.Rgs5Acta2.Rgs5)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.80e-05 | 69 | 38 | 3 | cdd42abdd072aa438830d837ee857529269a81e0 | |
| ToppCell | Thalamus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.87e-05 | 83 | 38 | 3 | 4017af9a4804a06d0f2cd0f285ebf1b582b751de | |
| ToppCell | Thalamus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Car4_(Mural.Rgs5Acta2.Car4)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.87e-05 | 83 | 38 | 3 | 59fce941d45f9763a8584f3fd5b7c0738de9f592 | |
| ToppCell | Thalamus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Car4_(Mural.Rgs5Acta2.Car4)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.87e-05 | 83 | 38 | 3 | ebabce70dc01fdeda7fccebc2c4a0b686cda580f | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Olfr558_(Mural.Rgs5Acta2.Olfr558)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.75e-05 | 101 | 38 | 3 | a05293ccd1de48ed8c7d1417f410d2c4be388c5b | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Olfr558_(Mural.Rgs5Acta2.Olfr558)|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.75e-05 | 101 | 38 | 3 | b75b000b7899399d1e6aa692d2a4c33b41a1fe18 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.25e-04 | 114 | 38 | 3 | 108cc5b04cc7c59310eb55dc2c44ae2b8e0b05e4 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Acinar_Adenocarcinoma-7|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.85e-04 | 130 | 38 | 3 | 0219d0d5d21df08f816569c7eb34f1bfa095d29a | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.30e-04 | 140 | 38 | 3 | 0e1e9281de87df178ac41ed6b697b4fa09be2749 | |
| ToppCell | Control-NK|World / Disease group and Cell class | 2.44e-04 | 143 | 38 | 3 | fe08adc9472dfd4242497d6c614d0490713261da | |
| Drug | mg 8 | 5.94e-07 | 11 | 36 | 3 | CID000069414 | |
| Drug | Copper silicide | 7.28e-06 | 3 | 36 | 2 | CID006336988 | |
| Drug | Acarbose | 1.46e-05 | 4 | 36 | 2 | DB00284 | |
| Drug | nimbidiol | 1.46e-05 | 4 | 36 | 2 | ctd:C496111 | |
| Drug | AC1L53LJ | 2.42e-05 | 5 | 36 | 2 | CID000197521 | |
| Drug | maltoheptose | 3.45e-05 | 40 | 36 | 3 | CID003037125 | |
| Drug | AC1OCFTL | 3.63e-05 | 6 | 36 | 2 | CID006918743 | |
| Drug | Glucose | 4.91e-05 | 1420 | 36 | 10 | ctd:D005947 | |
| Drug | isomaltotetraose | 5.08e-05 | 7 | 36 | 2 | CID003080783 | |
| Disease | alopecia areata (is_marker_for) | 5.77e-05 | 10 | 34 | 2 | DOID:986 (is_marker_for) | |
| Disease | Nephritis, Tubulointerstitial | 2.67e-04 | 21 | 34 | 2 | C0041349 | |
| Disease | BMI-adjusted fasting blood glucose measurement | 3.21e-04 | 23 | 34 | 2 | EFO_0008036 | |
| Disease | Nephritis, Interstitial | 3.50e-04 | 24 | 34 | 2 | C0027707 | |
| Disease | 1,5 anhydroglucitol measurement | 5.13e-04 | 29 | 34 | 2 | EFO_0008009 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MRCPEDEYAGYGYHS | 911 | Q76M96 | |
| QGYESFSYGGVDPYM | 76 | Q9H1K0 | |
| YGPMDDQGFYYGELG | 1606 | A6NNM3 | |
| YGPMDDQGFYYGELG | 1606 | A6NJZ7 | |
| GPKGDHTTGVGYYMY | 541 | Q7Z304 | |
| FYHMYGGGTGLLSVY | 586 | Q7Z304 | |
| DGDVGNYYYGQGHPM | 16 | Q13547 | |
| GDYDELGYMFPGHLG | 281 | Q4VC12 | |
| SYGVHPYYMGLEEDG | 1166 | O43451 | |
| PYYMGLEEDGSAHGV | 1171 | O43451 | |
| NSYGVHPYYMGLEED | 2061 | O43451 | |
| HPYYMGLEEDGSAHG | 2066 | O43451 | |
| AGEFMITFPYGYHAG | 266 | Q9H3R0 | |
| AGGAPDHSMLYYYGQ | 1436 | P10070 | |
| DYEPYPDDGMGYGDY | 61 | O95169 | |
| EGYPFYMAMGFPGYD | 166 | Q9P215 | |
| QPAPGMVYDYYEKDG | 1411 | Q6IE36 | |
| SYQGDMYPTRGVGYE | 311 | Q9NQ84 | |
| PADDHGYGVSYIFMG | 711 | Q8TCG5 | |
| TGPDYYRDMDIQYHG | 96 | Q68J44 | |
| KDLGDGVYGFEYYPM | 531 | P21333 | |
| TKSGGEYPYLMEAYG | 91 | P82251 | |
| FYDTGYTERYMGHPD | 786 | Q6V1X1 | |
| CEEPYYYMENGGGGE | 386 | P09871 | |
| PQDFYYVAMDFGGHG | 56 | Q9H4I8 | |
| LADMYGHPCGLEYGA | 776 | P55291 | |
| CEYYNEGLGEGPYML | 1206 | Q3ZCN5 | |
| DLKAYEQVMHYPGYG | 401 | Q9Y261 | |
| PQDFYYVAMDFGGHG | 56 | Q9NQF3 | |
| MRPGAYSTGYGGYEE | 231 | P52597 | |
| GEAMELYYGGHLCYG | 241 | A2RTX5 | |
| GRFMGDPSYEYEHTE | 101 | Q9H1X1 | |
| YGPMDDQGFYYGELG | 1606 | Q9UFD9 | |
| YMDTQYYGEIGIGTP | 81 | P00797 | |
| GYDEHEGPALYYMDY | 106 | P49721 | |
| GFYADPYLYHEGRMS | 391 | Q5T5P2 | |
| EDDYYSPHGMLANGS | 1916 | Q9HCD6 | |
| DGYLYMYNLDPQEGG | 351 | Q9Y4P8 | |
| SYGFHPYYMALEEEG | 1146 | P14410 | |
| PYYMALEEEGNAHGV | 1151 | P14410 | |
| EVGMRTLGEYHGYDP | 1041 | Q92626 | |
| YGPGSYGGMDRDYGH | 26 | Q5BKZ1 | |
| FSYGLQPYYGMAHEE | 796 | O15146 |